Available in: English, French, Chinese, Spanish, Russian, Arabic, Thai, Korean, Tajik, Vietnamese, Uzbek
http://www.who.int/disabilities/cbr/guidelines/en/
Int J Crit Illn Inj Sci. 2012 May-Aug; 2(2): 82–97.
doi: 10.4103/2229-5151.97273
PMCID: PMC3401822
PMID: 22837896
Рекомендации ВОЗ по оказанию дородовой помощи для формирования положительного опыта беременности
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Frequently asked questions on Antimicrobial resistance.
Abbreviated Report of a WHO Consultation
Public Report
PQMC 0003-003-00 WHO PQMC PR June/2015, version 2.0
Building laboratory testing capacity